Bernd Matiba

1.1k total citations
15 papers, 988 citations indexed

About

Bernd Matiba is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Bernd Matiba has authored 15 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Immunology. Recurrent topics in Bernd Matiba's work include Cell death mechanisms and regulation (5 papers), Pharmacology and Obesity Treatment (4 papers) and RNA Interference and Gene Delivery (4 papers). Bernd Matiba is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Pharmacology and Obesity Treatment (4 papers) and RNA Interference and Gene Delivery (4 papers). Bernd Matiba collaborates with scholars based in Germany, France and Canada. Bernd Matiba's co-authors include Peter H. Krammer, Sara M Mariani, Caroline Bäumler, Elena Armandola, A. Fontana, Michael Weller, Patrick Aebischer, Karl Frei, Anne Rensing‐Ehl and Iris Behrmann and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and Immunological Reviews.

In The Last Decade

Bernd Matiba

15 papers receiving 965 citations

Peers

Bernd Matiba
Adam B. Agranoff United States
Garvin L. Warner United States
Jacki Kornbluth United States
Baiqing Tang United States
David Weng United States
Ahmad M. Kamal United Kingdom
Guo‐Yun Chen United States
Adam B. Agranoff United States
Bernd Matiba
Citations per year, relative to Bernd Matiba Bernd Matiba (= 1×) peers Adam B. Agranoff

Countries citing papers authored by Bernd Matiba

Since Specialization
Citations

This map shows the geographic impact of Bernd Matiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Matiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Matiba more than expected).

Fields of papers citing papers by Bernd Matiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Matiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Matiba. The network helps show where Bernd Matiba may publish in the future.

Co-authorship network of co-authors of Bernd Matiba

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Matiba. A scholar is included among the top collaborators of Bernd Matiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Matiba. Bernd Matiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zeitlinger, Markus, et al.. (2025). Synergistic activity of fosfomycin and flucloxacillin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus: in vitro and in vivo assessment. Medical Microbiology and Immunology. 214(1). 32–32. 1 indexed citations
2.
Wirth, Alfred, et al.. (2006). Reduced left ventricular mass after treatment of obese patients with sibutramine: an echocardiographic multicentre study. Diabetes Obesity and Metabolism. 8(6). 674–681. 8 indexed citations
3.
Brennan, Alan, Roberta Ara, Raimund Sterz, Bernd Matiba, & R Bergemann. (2006). Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany. The European Journal of Health Economics. 7(4). 276–284. 9 indexed citations
4.
Wirth, Alfred, et al.. (2006). Reduced left ventricular mass after treatment of obese patients with sibutramine: an echocardiographic multicentre study. Diabetes Obesity and Metabolism. 0(0). 3131060479–3131060479. 1 indexed citations
5.
Jordan, Jens, J. Scholze, Bernd Matiba, et al.. (2005). Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials. International Journal of Obesity. 29(5). 509–516. 65 indexed citations
6.
Matiba, Bernd, Sara M Mariani, & Peter H. Krammer. (1997). The CD95 system and the death of a lymphocyte. Seminars in Immunology. 9(1). 59–68. 52 indexed citations
7.
Mariani, Sara M, Bernd Matiba, Elena Armandola, & Peter H. Krammer. (1997). Interleukin 1β-converting Enzyme Related Proteases/Caspases Are Involved in TRAIL-induced Apoptosis of Myeloma and Leukemia Cells. The Journal of Cell Biology. 137(1). 221–229. 130 indexed citations
8.
Mariani, Sara M, Bernd Matiba, Titus Sparna, & Peter H. Krammer. (1996). Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system. Journal of Immunological Methods. 193(1). 63–70. 21 indexed citations
9.
Mariani, Sara M, Bernd Matiba, & Peter H. Krammer. (1996). CD95 (APO-1/Fas) and its ligand in the mouse immune system.. PubMed. 12–23. 3 indexed citations
10.
Mariani, Sara M, et al.. (1995). Clonal deletion of major histocompatibility complex class I‐restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO‐1/Fas) ligand. European Journal of Immunology. 25(10). 2996–2999. 18 indexed citations
11.
Rensing‐Ehl, Anne, Karl Frei, Bernd Matiba, et al.. (1995). Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivo. European Journal of Immunology. 25(8). 2253–2258. 174 indexed citations
12.
Mariani, Sara M, Bernd Matiba, Caroline Bäumler, & Peter H. Krammer. (1995). Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteases. European Journal of Immunology. 25(8). 2303–2307. 191 indexed citations
13.
Mariani, Sara M, Bernd Matiba, Elena Armandola, & Peter H. Krammer. (1994). The APO‐1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. European Journal of Immunology. 24(12). 3119–3123. 58 indexed citations
14.
Tiegs, Gisa, Johannes Barsig, Bernd Matiba, Stefan Uhlig, & Albrecht Wendel. (1994). Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.. Journal of Clinical Investigation. 93(6). 2616–2622. 56 indexed citations
15.
Krammer, Peter H., Jens Dhein, Henning Walczak, et al.. (1994). The Role of APO‐1‐Mediated Apoptosis in the Immune System. Immunological Reviews. 142(1). 175–191. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026